The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Next-Generation Drug-Eluting Stent Market Research Report 2025
Synopsis
Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.
The global Next-Generation Drug-Eluting Stent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Next-Generation Drug-Eluting Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Drug-Eluting Stent.
Report Scope
The Next-Generation Drug-Eluting Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next-Generation Drug-Eluting Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next-Generation Drug-Eluting Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Biosensors International
Medtronic
Sorin Group
SMT
Terumo
Segment by Type
Cobalt Chromium
Stainless Steel
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Next-Generation Drug-Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Next-Generation Drug-Eluting Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.
The global Next-Generation Drug-Eluting Stent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Next-Generation Drug-Eluting Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Drug-Eluting Stent.
Report Scope
The Next-Generation Drug-Eluting Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next-Generation Drug-Eluting Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next-Generation Drug-Eluting Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Biosensors International
Medtronic
Sorin Group
SMT
Terumo
Segment by Type
Cobalt Chromium
Stainless Steel
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Next-Generation Drug-Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Next-Generation Drug-Eluting Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Next-Generation Drug-Eluting Stent Market Overview
1.1 Product Overview and Scope of Next-Generation Drug-Eluting Stent
1.2 Next-Generation Drug-Eluting Stent Segment by Type
1.2.1 Global Next-Generation Drug-Eluting Stent Market Value Comparison by Type (2024-2030)
1.2.2 Cobalt Chromium
1.2.3 Stainless Steel
1.2.4 Others
1.3 Next-Generation Drug-Eluting Stent Segment by Application
1.3.1 Global Next-Generation Drug-Eluting Stent Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Next-Generation Drug-Eluting Stent Market Size Estimates and Forecasts
1.4.1 Global Next-Generation Drug-Eluting Stent Revenue 2019-2030
1.4.2 Global Next-Generation Drug-Eluting Stent Sales 2019-2030
1.4.3 Global Next-Generation Drug-Eluting Stent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Next-Generation Drug-Eluting Stent Market Competition by Manufacturers
2.1 Global Next-Generation Drug-Eluting Stent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Next-Generation Drug-Eluting Stent Average Price by Manufacturers (2019-2024)
2.4 Global Next-Generation Drug-Eluting Stent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Product Type & Application
2.7 Next-Generation Drug-Eluting Stent Market Competitive Situation and Trends
2.7.1 Next-Generation Drug-Eluting Stent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Next-Generation Drug-Eluting Stent Players Market Share by Revenue
2.7.3 Global Next-Generation Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Next-Generation Drug-Eluting Stent Retrospective Market Scenario by Region
3.1 Global Next-Generation Drug-Eluting Stent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Next-Generation Drug-Eluting Stent Global Next-Generation Drug-Eluting Stent Sales by Region: 2019-2030
3.2.1 Global Next-Generation Drug-Eluting Stent Sales by Region: 2019-2024
3.2.2 Global Next-Generation Drug-Eluting Stent Sales by Region: 2025-2030
3.3 Global Next-Generation Drug-Eluting Stent Global Next-Generation Drug-Eluting Stent Revenue by Region: 2019-2030
3.3.1 Global Next-Generation Drug-Eluting Stent Revenue by Region: 2019-2024
3.3.2 Global Next-Generation Drug-Eluting Stent Revenue by Region: 2025-2030
3.4 North America Next-Generation Drug-Eluting Stent Market Facts & Figures by Country
3.4.1 North America Next-Generation Drug-Eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Next-Generation Drug-Eluting Stent Sales by Country (2019-2030)
3.4.3 North America Next-Generation Drug-Eluting Stent Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Next-Generation Drug-Eluting Stent Market Facts & Figures by Country
3.5.1 Europe Next-Generation Drug-Eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Next-Generation Drug-Eluting Stent Sales by Country (2019-2030)
3.5.3 Europe Next-Generation Drug-Eluting Stent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Next-Generation Drug-Eluting Stent Market Facts & Figures by Country
3.6.1 Asia Pacific Next-Generation Drug-Eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Next-Generation Drug-Eluting Stent Sales by Country (2019-2030)
3.6.3 Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Next-Generation Drug-Eluting Stent Market Facts & Figures by Country
3.7.1 Latin America Next-Generation Drug-Eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Next-Generation Drug-Eluting Stent Sales by Country (2019-2030)
3.7.3 Latin America Next-Generation Drug-Eluting Stent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Next-Generation Drug-Eluting Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Next-Generation Drug-Eluting Stent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Next-Generation Drug-Eluting Stent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Next-Generation Drug-Eluting Stent Sales by Type (2019-2030)
4.1.1 Global Next-Generation Drug-Eluting Stent Sales by Type (2019-2024)
4.1.2 Global Next-Generation Drug-Eluting Stent Sales by Type (2025-2030)
4.1.3 Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2030)
4.2 Global Next-Generation Drug-Eluting Stent Revenue by Type (2019-2030)
4.2.1 Global Next-Generation Drug-Eluting Stent Revenue by Type (2019-2024)
4.2.2 Global Next-Generation Drug-Eluting Stent Revenue by Type (2025-2030)
4.2.3 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2019-2030)
4.3 Global Next-Generation Drug-Eluting Stent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Next-Generation Drug-Eluting Stent Sales by Application (2019-2030)
5.1.1 Global Next-Generation Drug-Eluting Stent Sales by Application (2019-2024)
5.1.2 Global Next-Generation Drug-Eluting Stent Sales by Application (2025-2030)
5.1.3 Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2030)
5.2 Global Next-Generation Drug-Eluting Stent Revenue by Application (2019-2030)
5.2.1 Global Next-Generation Drug-Eluting Stent Revenue by Application (2019-2024)
5.2.2 Global Next-Generation Drug-Eluting Stent Revenue by Application (2025-2030)
5.2.3 Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2019-2030)
5.3 Global Next-Generation Drug-Eluting Stent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Next-Generation Drug-Eluting Stent Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Biosensors International
6.2.1 Biosensors International Corporation Information
6.2.2 Biosensors International Description and Business Overview
6.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biosensors International Next-Generation Drug-Eluting Stent Product Portfolio
6.2.5 Biosensors International Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Next-Generation Drug-Eluting Stent Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Sorin Group
6.4.1 Sorin Group Corporation Information
6.4.2 Sorin Group Description and Business Overview
6.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sorin Group Next-Generation Drug-Eluting Stent Product Portfolio
6.4.5 Sorin Group Recent Developments/Updates
6.5 SMT
6.5.1 SMT Corporation Information
6.5.2 SMT Description and Business Overview
6.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SMT Next-Generation Drug-Eluting Stent Product Portfolio
6.5.5 SMT Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Next-Generation Drug-Eluting Stent Product Portfolio
6.6.5 Terumo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Next-Generation Drug-Eluting Stent Industry Chain Analysis
7.2 Next-Generation Drug-Eluting Stent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Next-Generation Drug-Eluting Stent Production Mode & Process
7.4 Next-Generation Drug-Eluting Stent Sales and Marketing
7.4.1 Next-Generation Drug-Eluting Stent Sales Channels
7.4.2 Next-Generation Drug-Eluting Stent Distributors
7.5 Next-Generation Drug-Eluting Stent Customers
8 Next-Generation Drug-Eluting Stent Market Dynamics
8.1 Next-Generation Drug-Eluting Stent Industry Trends
8.2 Next-Generation Drug-Eluting Stent Market Drivers
8.3 Next-Generation Drug-Eluting Stent Market Challenges
8.4 Next-Generation Drug-Eluting Stent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Next-Generation Drug-Eluting Stent Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Next-Generation Drug-Eluting Stent Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Next-Generation Drug-Eluting Stent Market Competitive Situation by Manufacturers in 2023
Table 4. Global Next-Generation Drug-Eluting Stent Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Next-Generation Drug-Eluting Stent Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Next-Generation Drug-Eluting Stent Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Next-Generation Drug-Eluting Stent Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Next-Generation Drug-Eluting Stent, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Product Type & Application
Table 12. Global Key Manufacturers of Next-Generation Drug-Eluting Stent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Next-Generation Drug-Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Drug-Eluting Stent as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Next-Generation Drug-Eluting Stent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Next-Generation Drug-Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 18. Global Next-Generation Drug-Eluting Stent Sales Market Share by Region (2019-2024)
Table 19. Global Next-Generation Drug-Eluting Stent Sales by Region (2025-2030) & (K Units)
Table 20. Global Next-Generation Drug-Eluting Stent Sales Market Share by Region (2025-2030)
Table 21. Global Next-Generation Drug-Eluting Stent Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Region (2019-2024)
Table 23. Global Next-Generation Drug-Eluting Stent Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Region (2025-2030)
Table 25. North America Next-Generation Drug-Eluting Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Next-Generation Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 27. North America Next-Generation Drug-Eluting Stent Sales by Country (2025-2030) & (K Units)
Table 28. North America Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Next-Generation Drug-Eluting Stent Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Next-Generation Drug-Eluting Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Next-Generation Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 32. Europe Next-Generation Drug-Eluting Stent Sales by Country (2025-2030) & (K Units)
Table 33. Europe Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Next-Generation Drug-Eluting Stent Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Next-Generation Drug-Eluting Stent Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Next-Generation Drug-Eluting Stent Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Next-Generation Drug-Eluting Stent Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Next-Generation Drug-Eluting Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Next-Generation Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Next-Generation Drug-Eluting Stent Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Next-Generation Drug-Eluting Stent Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Next-Generation Drug-Eluting Stent Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Next-Generation Drug-Eluting Stent Sales (K Units) by Type (2019-2024)
Table 51. Global Next-Generation Drug-Eluting Stent Sales (K Units) by Type (2025-2030)
Table 52. Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2019-2024)
Table 53. Global Next-Generation Drug-Eluting Stent Sales Market Share by Type (2025-2030)
Table 54. Global Next-Generation Drug-Eluting Stent Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Next-Generation Drug-Eluting Stent Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2019-2024)
Table 57. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Type (2025-2030)
Table 58. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Type (2019-2024)
Table 59. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Type (2025-2030)
Table 60. Global Next-Generation Drug-Eluting Stent Sales (K Units) by Application (2019-2024)
Table 61. Global Next-Generation Drug-Eluting Stent Sales (K Units) by Application (2025-2030)
Table 62. Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2019-2024)
Table 63. Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2025-2030)
Table 64. Global Next-Generation Drug-Eluting Stent Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Next-Generation Drug-Eluting Stent Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2019-2024)
Table 67. Global Next-Generation Drug-Eluting Stent Revenue Market Share by Application (2025-2030)
Table 68. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Application (2019-2024)
Table 69. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Application (2025-2030)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Abbott Next-Generation Drug-Eluting Stent Product
Table 74. Abbott Recent Developments/Updates
Table 75. Biosensors International Corporation Information
Table 76. Biosensors International Description and Business Overview
Table 77. Biosensors International Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Biosensors International Next-Generation Drug-Eluting Stent Product
Table 79. Biosensors International Recent Developments/Updates
Table 80. Medtronic Corporation Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Medtronic Next-Generation Drug-Eluting Stent Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Sorin Group Corporation Information
Table 86. Sorin Group Description and Business Overview
Table 87. Sorin Group Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sorin Group Next-Generation Drug-Eluting Stent Product
Table 89. Sorin Group Recent Developments/Updates
Table 90. SMT Corporation Information
Table 91. SMT Description and Business Overview
Table 92. SMT Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. SMT Next-Generation Drug-Eluting Stent Product
Table 94. SMT Recent Developments/Updates
Table 95. Terumo Corporation Information
Table 96. Terumo Description and Business Overview
Table 97. Terumo Next-Generation Drug-Eluting Stent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Terumo Next-Generation Drug-Eluting Stent Product
Table 99. Terumo Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Next-Generation Drug-Eluting Stent Distributors List
Table 103. Next-Generation Drug-Eluting Stent Customers List
Table 104. Next-Generation Drug-Eluting Stent Market Trends
Table 105. Next-Generation Drug-Eluting Stent Market Drivers
Table 106. Next-Generation Drug-Eluting Stent Market Challenges
Table 107. Next-Generation Drug-Eluting Stent Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Next-Generation Drug-Eluting Stent
Figure 2. Global Next-Generation Drug-Eluting Stent Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Next-Generation Drug-Eluting Stent Market Share by Type in 2023 & 2030
Figure 4. Cobalt Chromium Product Picture
Figure 5. Stainless Steel Product Picture
Figure 6. Others Product Picture
Figure 7. Global Next-Generation Drug-Eluting Stent Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Next-Generation Drug-Eluting Stent Market Share by Application in 2023 & 2030
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Ambulatory Surgical Centers
Figure 12. Global Next-Generation Drug-Eluting Stent Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Next-Generation Drug-Eluting Stent Market Size (2019-2030) & (US$ Million)
Figure 14. Global Next-Generation Drug-Eluting Stent Sales (2019-2030) & (K Units)
Figure 15. Global Next-Generation Drug-Eluting Stent Average Price (USD/Unit) & (2019-2030)
Figure 16. Next-Generation Drug-Eluting Stent Report Years Considered
Figure 17. Next-Generation Drug-Eluting Stent Sales Share by Manufacturers in 2023
Figure 18. Global Next-Generation Drug-Eluting Stent Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Next-Generation Drug-Eluting Stent Players: Market Share by Revenue in 2023
Figure 20. Next-Generation Drug-Eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Next-Generation Drug-Eluting Stent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Next-Generation Drug-Eluting Stent Sales Market Share by Country (2019-2030)
Figure 23. North America Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Next-Generation Drug-Eluting Stent Sales Market Share by Country (2019-2030)
Figure 27. Europe Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2019-2030)
Figure 28. Germany Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Next-Generation Drug-Eluting Stent Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Next-Generation Drug-Eluting Stent Revenue Market Share by Region (2019-2030)
Figure 35. China Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Next-Generation Drug-Eluting Stent Sales Market Share by Country (2019-2030)
Figure 46. Latin America Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Next-Generation Drug-Eluting Stent Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Next-Generation Drug-Eluting Stent Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Next-Generation Drug-Eluting Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Next-Generation Drug-Eluting Stent by Type (2019-2030)
Figure 56. Global Revenue Market Share of Next-Generation Drug-Eluting Stent by Type (2019-2030)
Figure 57. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Next-Generation Drug-Eluting Stent by Application (2019-2030)
Figure 59. Global Revenue Market Share of Next-Generation Drug-Eluting Stent by Application (2019-2030)
Figure 60. Global Next-Generation Drug-Eluting Stent Price (USD/Unit) by Application (2019-2030)
Figure 61. Next-Generation Drug-Eluting Stent Value Chain
Figure 62. Next-Generation Drug-Eluting Stent Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
